HK1137947A1 - Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria - Google Patents

Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria

Info

Publication number
HK1137947A1
HK1137947A1 HK10104970.4A HK10104970A HK1137947A1 HK 1137947 A1 HK1137947 A1 HK 1137947A1 HK 10104970 A HK10104970 A HK 10104970A HK 1137947 A1 HK1137947 A1 HK 1137947A1
Authority
HK
Hong Kong
Prior art keywords
ameliorating
treating
reducing
compositions
methods
Prior art date
Application number
HK10104970.4A
Other languages
English (en)
Inventor
Praveen Tyle
Pramod Kumar Gupta
Susan E Norton
Lynne Brunner
Joseph Blondeau
Original Assignee
Bausch & Lomb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bausch & Lomb filed Critical Bausch & Lomb
Publication of HK1137947A1 publication Critical patent/HK1137947A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK10104970.4A 2007-03-21 2010-05-20 Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria HK1137947A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89608207P 2007-03-21 2007-03-21
PCT/US2008/057427 WO2008115951A1 (en) 2007-03-21 2008-03-19 Fluoroquinolones for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria

Publications (1)

Publication Number Publication Date
HK1137947A1 true HK1137947A1 (en) 2010-08-13

Family

ID=39673162

Family Applications (1)

Application Number Title Priority Date Filing Date
HK10104970.4A HK1137947A1 (en) 2007-03-21 2010-05-20 Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria

Country Status (12)

Country Link
US (1) US8937062B2 (de)
EP (1) EP2136812B1 (de)
JP (1) JP2010522192A (de)
KR (2) KR20090114465A (de)
CN (1) CN101641100A (de)
AU (1) AU2008228941B2 (de)
BR (1) BRPI0808823A2 (de)
CA (1) CA2679626C (de)
ES (1) ES2427596T3 (de)
HK (1) HK1137947A1 (de)
MX (1) MX2009009657A (de)
WO (1) WO2008115951A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173640B1 (en) 2007-05-18 2012-05-08 Bausch & Lomb Incorporated Compositions and methods for treating, reducing, ameliorating, or preventing infections
US20090054406A1 (en) * 2007-08-21 2009-02-26 Ward Keith W Compositions and Methods for Modulating Endophthalmitis Using Fluoroquinolones
US20090082337A1 (en) * 2007-09-21 2009-03-26 Srini Venkastesh Compositions Comprising Quinolone and Methods for Treating or Controlling Infections
US20130296223A1 (en) * 2012-03-30 2013-11-07 Sciclone Pharmaceuticals, Inc. Use of thymosin alpha for the treatment of sepsis
KR102361131B1 (ko) * 2020-02-25 2022-02-10 경희대학교 산학협력단 항생제 내성 균주에 대해 항균활성을 갖는 항균용 조성물
CN114957279B (zh) * 2022-05-30 2023-08-01 中国人民解放军军事科学院军事医学研究院 二氢噻吩并[2,3-e]吲唑类化合物、药物组合物及应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2613139B2 (ja) * 1990-07-19 1997-05-21 エスエス製薬 株式会社 キノロンカルボン酸誘導体
US6699492B2 (en) * 1999-03-31 2004-03-02 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US6685958B2 (en) 2001-04-25 2004-02-03 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
JP5089165B2 (ja) * 2003-04-09 2012-12-05 バイヤースドルフ・アクチエンゲゼルシヤフト 抗菌物質
US20050085446A1 (en) * 2003-04-14 2005-04-21 Babu M.K. M. Fluoroquinolone formulations and methods of making and using the same
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods

Also Published As

Publication number Publication date
WO2008115951A1 (en) 2008-09-25
ES2427596T3 (es) 2013-10-31
CN101641100A (zh) 2010-02-03
CA2679626A1 (en) 2008-09-25
BRPI0808823A2 (pt) 2017-10-10
AU2008228941A1 (en) 2008-09-25
AU2008228941B2 (en) 2011-12-01
US20080261900A1 (en) 2008-10-23
MX2009009657A (es) 2009-09-22
KR20090114465A (ko) 2009-11-03
EP2136812B1 (de) 2013-09-04
KR20130010131A (ko) 2013-01-25
US8937062B2 (en) 2015-01-20
EP2136812A1 (de) 2009-12-30
JP2010522192A (ja) 2010-07-01
CA2679626C (en) 2012-10-23

Similar Documents

Publication Publication Date Title
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
AU2015205914B2 (en) 1,6- diazabicyclo [3,2,1] octan- 7- one derivatives and their use in the treatment of bacterial infections
MX349827B (es) Compuestos que contienen nitrogeno y su uso.
GEP20156370B (en) Fluoro-pyridinone derivatives useful as antibacterial agents
MX340533B (es) Derivados de 1,6- diazabiciclo [3,2,1] octan-7-ona y su uso en el tratamiento de infecciones bacterianas.
MX2012001156A (es) Moleculas que contienen boro trisustituidas.
UA105390C2 (ru) МОТИВЫ ХИМИЧЕСКИХ МОДИФИКАЦИЙ ДЛЯ ИНГИБИТОРОВ И МИМЕТИКОВ мкРНК
MX2012010671A (es) Compuestos antiinfecciosos.
MX2009006846A (es) Derivados de tetraciclina para el tratamiento de infecciones bacterianas, virales y parasitarias.
MX2015007556A (es) Derivados de manosa para tratar infecciones bacterianas.
MX338610B (es) Composiciones farmaceuticas que comprenden sulbactam e inhibidor de beta-lactamasa.
EA021554B9 (ru) Органические соединения и их применение для лечения hcv инфекции
TW200734334A (en) Treatment of substance abuse
MX2013009252A (es) Composiciones y procesos relacionados con los mismos plaguicidas.
MX363678B (es) Terapia de combinación que comprende oxazolidinona-quinolonas para usarse en el tratamiento de infecciones bacterianas.
NZ596628A (en) Ketolide compounds having antimicrobial activity
MX2016009248A (es) Compuestos que contienen nitrogeno y su uso como agentes antibacterianos.
IN2012DN00374A (de)
MX2011005425A (es) Derivados de carboxiamida lantibiotica con actividad antibacteriana mejorada.
HK1137947A1 (en) Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria
GEP20186876B (en) Heterobicycloaryl rorc2 inhibitors and methods of use thereof
IN2012DN01414A (de)
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
MX2015005753A (es) Agentes antimicrobianos.
BR112015016033A8 (pt) composições farmacêuticas para tratamento de infecções por bactérias, e seus usos

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170319